Advances in Radiation Therapy: Treating Cancer in the Age of Star Trek

Subscribe to The Vet Blast Podcast on Apple Podcasts, Spotify, or wherever you get your podcasts. This episode is sponsored by Nationwide.

On this episode of the Vet Blast Podcast, Adam Christman, DVM, MBA, is joined by Neal Mauldin, DVM, DACVIM (Internal Medicine) and (Oncology), ACVR (Radiation Oncology) to discuss radiation therapy for oncology patients, including the science behind it, cost of treatment, and recent advancements.

Below is a partial transcript. Listen to the full podcast for more.

Neal Mauldin, DVM, DACVIM (Internal Medicine) and (Oncology), ACVR (Radiation Oncology): I'd say probably one of the biggest things driving the push towards stereotactic radiation is just we're 10 years in now and we are starting to accrue data that is meaningful data. You know, in the early days, we'd be like, well, this is what they do in people, let's give it a try and see how it goes. And now we're getting pretty confident, you know, for brain tumors and for nasal tumors, we're pretty confident in what we can accomplish with stereotactic. The other thing because of that, imaging and target acquisition certainty that we have now, there are things we'll treat with radiation that were completely off limits before because we couldn't target well enough.